IT1290910B1 - 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive - Google Patents

2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive

Info

Publication number
IT1290910B1
IT1290910B1 IT97RM000050A ITRM970050A IT1290910B1 IT 1290910 B1 IT1290910 B1 IT 1290910B1 IT 97RM000050 A IT97RM000050 A IT 97RM000050A IT RM970050 A ITRM970050 A IT RM970050A IT 1290910 B1 IT1290910 B1 IT 1290910B1
Authority
IT
Italy
Prior art keywords
active
preparation
pharmaceutical compositions
aminotetraline
procedure
Prior art date
Application number
IT97RM000050A
Other languages
English (en)
Inventor
Gian Piero Moretti
Piero Foresta
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT97RM000050A priority Critical patent/IT1290910B1/it
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to ES98902173T priority patent/ES2190581T3/es
Priority to JP53269398A priority patent/JP2001509802A/ja
Priority to DE69810906T priority patent/DE69810906T2/de
Priority to PT98902173T priority patent/PT968174E/pt
Priority to EP98902173A priority patent/EP0968174B1/en
Priority to PCT/IT1998/000011 priority patent/WO1998033762A1/en
Priority to AT98902173T priority patent/ATE231486T1/de
Priority to US09/341,762 priority patent/US6225501B1/en
Priority to DK98902173T priority patent/DK0968174T3/da
Publication of ITRM970050A1 publication Critical patent/ITRM970050A1/it
Application granted granted Critical
Publication of IT1290910B1 publication Critical patent/IT1290910B1/it
Priority to HK00102411A priority patent/HK1025558A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
IT97RM000050A 1997-02-03 1997-02-03 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive IT1290910B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT97RM000050A IT1290910B1 (it) 1997-02-03 1997-02-03 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
JP53269398A JP2001509802A (ja) 1997-02-03 1998-01-28 光学活性な２−アミノテトラリン、その製法および該化合物を含有する敗血症性ショックを予防または治療するための医薬組成物
DE69810906T DE69810906T2 (de) 1997-02-03 1998-01-28 Optisch aktive 2-amino-tetraline, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten und die nützlich sind zur vorbeugung und behandlung von septischem schock
PT98902173T PT968174E (pt) 1997-02-03 1998-01-28 2-aminotetralina opticamente activa processo para a sua preparacao e composicoes farmaceuticas contendo a mesma activas na prevencao e tratamento do choque septico
ES98902173T ES2190581T3 (es) 1997-02-03 1998-01-28 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
EP98902173A EP0968174B1 (en) 1997-02-03 1998-01-28 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock
PCT/IT1998/000011 WO1998033762A1 (en) 1997-02-03 1998-01-28 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock
AT98902173T ATE231486T1 (de) 1997-02-03 1998-01-28 Optisch aktive 2-amino-tetraline, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten und die nützlich sind zur vorbeugung und behandlung von septischem schock
US09/341,762 US6225501B1 (en) 1997-02-03 1998-01-28 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock
DK98902173T DK0968174T3 (da) 1997-02-03 1998-01-28 Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok
HK00102411A HK1025558A1 (en) 1997-02-03 2000-04-20 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000050A IT1290910B1 (it) 1997-02-03 1997-02-03 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive

Publications (2)

Publication Number Publication Date
ITRM970050A1 ITRM970050A1 (it) 1998-08-03
IT1290910B1 true IT1290910B1 (it) 1998-12-14

Family

ID=11404706

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97RM000050A IT1290910B1 (it) 1997-02-03 1997-02-03 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive

Country Status (11)

Country Link
US (1) US6225501B1 (it)
EP (1) EP0968174B1 (it)
JP (1) JP2001509802A (it)
AT (1) ATE231486T1 (it)
DE (1) DE69810906T2 (it)
DK (1) DK0968174T3 (it)
ES (1) ES2190581T3 (it)
HK (1) HK1025558A1 (it)
IT (1) IT1290910B1 (it)
PT (1) PT968174E (it)
WO (1) WO1998033762A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1294931B1 (it) 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
IT1317050B1 (it) * 2000-06-23 2003-05-26 Sigma Tau Ind Farmaceuti Tetraline 2,6,7-sostituite utili per la preparazione di un medicamentoad attivita' inibitrice della fosfodiesterasi iv.
CN103360360A (zh) * 2012-04-10 2013-10-23 肖竹平 一种基于二氢杨梅素制备(+)-没食子儿茶素的方法
JP2020536870A (ja) 2017-10-05 2020-12-17 バイオジェン インコーポレイテッド アルファカルボキサミドピロリジン誘導体の調製方法
CN114222728A (zh) * 2019-04-10 2022-03-22 生物基因公司 制备α-甲酰胺吡咯烷衍生物的方法
CN115724758A (zh) * 2021-08-24 2023-03-03 杭州中美华东制药有限公司 喜树碱衍生物中间体及其合成方法和利用中间体合成喜树碱衍生物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241988B (it) * 1990-06-15 1994-02-02 Sigma Tau Ind Farmaceuti 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
IT1278045B1 (it) * 1995-03-09 1997-11-17 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Also Published As

Publication number Publication date
HK1025558A1 (en) 2000-11-17
EP0968174A1 (en) 2000-01-05
ES2190581T3 (es) 2003-08-01
ITRM970050A1 (it) 1998-08-03
DK0968174T3 (da) 2003-05-12
ATE231486T1 (de) 2003-02-15
WO1998033762A1 (en) 1998-08-06
EP0968174B1 (en) 2003-01-22
US6225501B1 (en) 2001-05-01
DE69810906D1 (de) 2003-02-27
DE69810906T2 (de) 2003-11-13
PT968174E (pt) 2003-06-30
JP2001509802A (ja) 2001-07-24

Similar Documents

Publication Publication Date Title
SE9704546D0 (sv) Novel compounds
IL138028A0 (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical use
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
TR200100054T2 (tr) Paroksetin metansülfonat
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
HU9603495D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
ZA973647B (en) Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them.
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
AU7294098A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
ITFI930083A0 (it) Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
IT1287174B1 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
HUP9802408A3 (en) Naphthyl and dihydronaphthyl-derivatives, and pharmaceutical compositions, containing them
SE9802937D0 (sv) Novel compounds
ZA961138B (en) Solid active ingredient compositions containing hydroxypropylcellulose.
EP0683668A4 (en) PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION.
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
ZA949874B (en) B3-adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositions.
IT1297022B1 (it) Complesso di ferro-succinilcaseina, processo per la sua preparazione e composizioni farmaceutiche che lo contengono
IT9048066A0 (it) 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono.
ZA9810759B (en) Proliferatively active product for treating proliferating cells.
ITMI941696A0 (it) 8-fluoro-antracicline, loro processi di preparazione e composizioni farmaceutiche che le contengono
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial

Legal Events

Date Code Title Description
0001 Granted